Yohei Ouchi, Takehito Kishino, Takenori Miyashita, Terushige Mori, Katsuya Mitamura, Takashi Norikane, Yuka Yamamoto, Hiroshi Hoshikawa. Predictive value of local control by 4'-[methyl-11C]-thiotymidine PET volume parameters in p16-negative oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma. Nuclear medicine communications. 2024. 45. 5. 381-388
Kiriko Fujioka, Takashi Norikane, Yasukage Takami, Yuka Yamamoto, Takahisa Noma, Yoshihiro Nishiyama. Feasibility of PiB positron emission tomography/computed tomography for treatment monitoring with Tafamidis in a patient with transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology. 2024. 33. 101816
Takashi Norikane, Mariko Ishimura, Katsuya Mitamura, Yuka Yamamoto, Hanae Arai-Okuda, Yuri Manabe, Mitsumasa Murao, Riku Morita, Takafumi Obata, Kenichi Tanaka, et al. Texture Features of 18F-Fluorodeoxyglucose Positron Emission Tomography for Predicting Programmed Death-Ligand-1 Levels in Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 2024. 13. 6. 1625
Takashi Norikane, Yuka Yamamoto, Yasukage Takami, Katsuya Mitamura, Takuya Kobata, Yukito Maeda, Takahisa Noma, Yoshihiro Nishiyama. Physiological myocardial F-FDG uptake pattern in oncologic PET/CT: comparison with findings in cardiac sarcoidosis. Asia Oceania journal of nuclear medicine & biology. 2024. 12. 1. 1-10
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Hanae Arai-Okuda, Tetsuhiro Hatakeyama, Keisuke Miyake, Yoshihiro Nishiyama. Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of Neuro-Oncology. 2023. 166. 1. 195-201
Textural Indices Extracted from FMISO and FLT PET/CT for Predicting IDH1 Mutation in Newly Diagnosed High-grade Gliomas
(RSNA2023 2023)
Correlation of FLT PET Findings with Histopathology in the Assessment of Response to Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Comparison with FDG PET
(RSNA2023 2023)